DBV Technologies | DBVT - Mitarbeiter Gesamtzahl





Mitarbeiter Veränderung Datum
Acadia Pharmaceuticals 653 56 2024-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
Amarin 275 90 2023-12
BioCryst Pharmaceuticals 536 5 2023-12
BioMarin Pharmaceutical 3.04K 361 2024-12
DBV Technologies USD 104 19 2023-12
Esperion Therapeutics 240 41 2023-12
Galectin Therapeutics 14 2 2023-12
Halozyme Therapeutics 350 23 2024-12
Incyte 2.62K 93 2024-12
Insmed 1.27K 359 2024-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Neurocrine Biosciences 1.8K 400 2024-12
PTC Therapeutics 939 49 2024-12
Sarepta Therapeutics 1.37K 58 2024-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
United Therapeutics 1.3K 137 2024-12